成大生物
(688739)
| 流通市值：113.82亿 | | | 总市值：113.82亿 |
| 流通股本：4.16亿 | | | 总股本：4.16亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 706,777,261.37 | 358,395,731.16 | 1,676,241,143.62 | 1,302,689,599.82 |
| 营业收入 | 706,777,261.37 | 358,395,731.16 | 1,676,241,143.62 | 1,302,689,599.82 |
| 二、营业总成本 | 546,367,052.07 | 273,025,862.02 | 1,195,983,007.01 | 872,113,905.3 |
| 营业成本 | 147,698,947.9 | 86,447,677.95 | 286,002,805.26 | 222,550,389.8 |
| 税金及附加 | 10,337,727.51 | 5,030,834.78 | 22,627,720.02 | 16,947,394.51 |
| 销售费用 | 184,362,907.33 | 88,186,186.15 | 421,259,791.15 | 299,221,885.06 |
| 管理费用 | 104,162,853.16 | 52,503,772.74 | 236,765,506.25 | 166,310,583.93 |
| 研发费用 | 121,438,891.32 | 51,861,758.56 | 282,932,719.22 | 207,277,477.75 |
| 财务费用 | -21,634,275.15 | -11,004,368.16 | -53,605,534.89 | -40,193,825.75 |
| 其中:利息费用 | 329,773.44 | 168,872.28 | 1,578,015.37 | 643,979.17 |
| 其中:利息收入 | 21,355,757.87 | 10,955,568.33 | 54,945,255.59 | 41,015,216.17 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -2,669,752.62 | 2,161,793.47 | -33,421,748.59 | -15,935,793.6 |
| 加:投资收益 | 13,267,031.43 | 4,408,104.7 | 15,549,868.15 | 14,609,762.67 |
| 资产处置收益 | - | - | 88,290.32 | 90,854.59 |
| 资产减值损失(新) | -16,369,205.15 | -8,142,887.42 | -75,387,882.53 | -26,455,350.8 |
| 信用减值损失(新) | -16,278,382.87 | -7,672,350.59 | -8,341,830 | -11,138,182.19 |
| 其他收益 | 8,164,634.44 | 4,315,669.53 | 26,903,599.28 | 15,240,836.32 |
| 四、营业利润 | 146,524,534.53 | 80,440,198.83 | 405,648,433.24 | 406,987,821.51 |
| 加:营业外收入 | 122,731.86 | 39,931.87 | 115,860 | 111,700 |
| 减:营业外支出 | 686,777.9 | 327,884.65 | 2,739,355.12 | 1,937,324.57 |
| 五、利润总额 | 145,960,488.49 | 80,152,246.05 | 403,024,938.12 | 405,162,196.94 |
| 减:所得税费用 | 23,665,813.24 | 7,934,240.8 | 60,203,383.85 | 75,464,068.9 |
| 六、净利润 | 122,294,675.25 | 72,218,005.25 | 342,821,554.27 | 329,698,128.04 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 122,294,675.25 | 72,218,005.25 | 342,821,554.27 | 329,698,128.04 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 122,294,675.25 | 72,218,005.25 | 342,821,554.27 | 329,698,128.04 |
| 扣除非经常损益后的净利润 | 101,983,324.99 | 62,571,208.97 | 323,772,266.53 | 311,957,559.89 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.3 | 0.18 | 0.83 | 0.8 |
| (二)稀释每股收益 | 0.3 | 0.18 | 0.83 | 0.8 |
| 九、综合收益总额 | 122,294,675.25 | 72,218,005.25 | 342,821,554.27 | 329,698,128.04 |
| 归属于母公司股东的综合收益总额 | 122,294,675.25 | 72,218,005.25 | 342,821,554.27 | 329,698,128.04 |
| 公告日期 | 2025-08-29 | 2025-04-30 | 2025-04-24 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |